BerandaBCRX • NASDAQ
add
BioCryst Pharmaceuticals Inc
$6,67
Sebelum Jam Perdagangan Normal:(0,15%)+0,0100
$6,68
Tutup: 21 Jan, 08.21.26 GMT-5 · USD · NASDAQ · Pernyataan Penyangkalan
Tutup sebelumnya
$6,67
Rentang tahun
$6,00 - $11,31
Kapitalisasi pasar
1,41Â M USD
Volume Rata-Rata
4,18Â jt
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Tentang
BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug peramivir was approved by FDA in December 2014. It has also been approved in Japan, Korea, and China. Wikipedia
Didirikan
1986
Kantor pusat
Situs
Karyawan
580